期刊文献+

冠心病患者高敏C-反应蛋白、低密度脂蛋白检测的意义 被引量:6

下载PDF
导出
摘要 随着生活水平的提高,冠心病(CHD)的发病率越来越高,研究表明炎症反应在心肌梗死发病机制中起重要作用。高敏C反应蛋白(hs-CRP)是人体的急性时相反应蛋白,作为血管炎症反应的标记物,hs-CRP血清水平有助于区分高危心血管疾病患者^[1]。而在CHD的发病中,低密度脂蛋白一胆固醇(LDL-C)起着重要的作用。本文通过对95例冠心病(CHD)患者血清hs-CRP及低密度脂蛋白LDL测定,结合临床资料综合分析,探讨hs-CRP、LDL与CHD病变程度的关系。
作者 柴广军
出处 《标记免疫分析与临床》 CAS 2012年第1期47-48,共2页 Labeled Immunoassays and Clinical Medicine
  • 相关文献

参考文献4

二级参考文献49

  • 1Zimmerm ann J, Herrlinger S, Prug A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients[J]. Kidney Int, 1999, 55:648.
  • 2Williams B B. Elavation of C -reactin in “active” coronary disease[J]. Am, Cardio,1990, 65 : 168.
  • 3Maier J. Cardiac troponin I and troponin T: Are enzymes still relevant as cardiac markers[J]. Clin Chim Acta, 1997,257:99.
  • 4Borgan GX, Vuori J, Friedman S, et al. Improved specificity of myoglobin plus carbonic anhydrase assay versus that of creatine kinase MB for early diagnosis of acute myocardial infarction [J]. Ann Emerg Med, 1996,27:22 - 28.
  • 5Luigi M, Giovanna L, Rita L, et al. Elevated levels of C -reactive protein at discharge in patients with unstable angina predict recurrent instability[J]. Clin Invest Rep,1998, 11:855 - 859.
  • 6Abdelmouttaleb I, Danchin N, Ilaedo C et al. C -reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes[J]. Am Heart J,1999, 137: 346.
  • 7Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384.
  • 8Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046.
  • 9Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118.
  • 10Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111.

共引文献320

同被引文献52

  • 1陈文彬,潘祥林.诊断学[M].第7版.北京:人民卫生出版社.2008:314-315.
  • 2王玉明,程亚萍,郭翀,等.血清淀粉样蛋白A与冠心病的相关性研究[J].临床术心血管病杂志,2011,27(10):739742.
  • 3Aratani Y,Kura F,Watanabe H,et al.In vivo role of myeloperoxidase for the host defense.Jpn Infect Dis,2004,57(5):S15.
  • 4Nauseef W M,Olsson I,Arnljots K.Biosynthesis and processing of myeloperoxidase-a marker for myeloid cell differentiation.Eur J Heamatol,1988,40 (2):97-110.
  • 5Brennan M L,Hazen S L.Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.Curr Opin Lipidol,2003,14(4):353-359.
  • 6Vita J A,Brennan M L,Gokce N,et al.Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.Circulation,2004,110 (9):1134-1139.
  • 7Davies M J,Thomas A C,KnapmanP A,et al.Intramyocardial platelet aggregation in patient with unstable angina suffering sudden ischemic cardiac death.Circulation,1986,73 (3):418-427.
  • 8Pitsavos C,Panagiotakos D B,Antonoulas A,et al.Epidemiology of acute coronary syndromes in a Mediterranean country; aims,design and baseline characteristics of the Greek study of acutecoronary syndromes (GREECS).BMC Public Health,2005,5:23.
  • 9Shao B,Bergt C,Fu X,et al.Tyrosine 192 apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase,but only chlorination markedly impairs ABCAl-dependent cholesterol transport.Biol Chem,2005,280(7):5983-5993.
  • 10Trepels T,Zeiher A M,Fichtlscherer S.Acute coronary syndrome and inflammation.Biomarkers for diagnostics and risk stratification,2004,29(8):796-776.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部